Mackenzie Financial
MYGN icon

Mackenzie Financial’s Myriad Genetics MYGN Stock Holding History

Mackenzie Financial’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.8M Buy
2,499,354
+963,652
+63% +$4.06M 0.01% 610
2026
Q2 		$8.77M Buy
+1,535,702
New +$6.97M 0.01% 677
2017
Q4 		– Sell
-210,697
Closed -$7.62M – 838
2017
Q3 		$7.62M Hold
210,697
– – 0.04% 295
2017
Q2 		$5.44M Buy
+210,697
New +$4.47M 0.03% 303

Other funds holding MYGN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Vise Technologies
Vise Technologies New York $12B AUM 18.78% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
Williams & Novak
Williams & Novak Westlake Village, California $169M AUM 17.63% 1-Year Est. Return

Mackenzie Financial's MYGN Position: Q3 2026 in Review

Mackenzie Financial increased its Myriad Genetics (MYGN) stake by 63% in Q3 2026, buying an estimated $4.06M and bringing the position to 2,499,354 shares worth $10.8M. The position accounts for 0.01% of the portfolio, ranked #610.

Mackenzie Financial first reported a position in MYGN in Q2 2017 and has held it in 4 quarters since. 36 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.

  • Mackenzie Financial held 2,499,354 shares of Myriad Genetics worth $10.8M as of Q3 2026.
  • Mackenzie Financial bought 963,652 Myriad Genetics shares in Q3 2026, an estimated $4.06M.
  • Myriad Genetics made up 0.01% of Mackenzie Financial's portfolio in Q3 2026, its #610 holding.
  • Mackenzie Financial first reported a position in Myriad Genetics in Q2 2017 and has held it in 4 quarters since.
  • 36 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.

Based on Mackenzie Financial's 13F filing for Q3 2026, filed 2 Nov 2026.